Agglomerated vesicle technology: A new class of particles for controlled and modulated pulmonary drug delivery

Journal of Controlled Release

Volumn 93, Issue 1, 2003, Pages 15-28

  Bhavane, Rohan ^a   Karathanasis, Efstathios ^a   Annapragada, Ananth V ^a,b  

^a CLEVELAND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Aerosol drug delivery; Agglomerated vesicle technology; Ciprofloxacin; Controlled and modulated release; Liposomes

Indexed keywords

ESTERS; PULMONARY DISEASES;

NANOPARTICLES;

DRUG INTERACTIONS;

CARBONYL DERIVATIVE; CIPROFLOXACIN; LIPOSOME; NANOPARTICLE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHALATIONAL DRUG ADMINISTRATION; NEBULIZATION; PRIORITY JOURNAL; RESPIRATORY SYSTEM;

EID: 0242384077     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00359-6     Document Type: Article

References (30)

1. T. Mckone, B. Huey, E. Downing, L. Duffy, Strategies to protect the health of deployed U.S. forces: detecting, characterizing, and documenting exposures, in: Division of Military Science and Technology and Board on Environmental Studies and Toxicology, National Research Council (Ed.), 2000.
2. Conley J., Yang H., Wilson T., Blasetti K., Di Ninno V., Schnell G., Wong J. Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularenis infection in mice. Antimicrobial Agents and Chemotherapy. 41(6):1997;1288-1292.
3. Adjei A.L., Gupta P.K. Inhalation Delivery of Therapeutic Peptides and Proteins. 1997;Marcel Dekker, New York.
4. Edwards D., Hanes J., Caponetti G., Hrkach J., Ben-Jebria A., Eskew M., Mintzes J., Deaver D., Lotan N., Langer R. Large porous particles for pulmonary drug delivery. Science. 276:1997;1868-1871.
5. Dellamary L., Tarara T., Smith D., Woelk H., Adractas A., Costello M., Gill H., Weers J. Hollow porous particles in metered dose inhalers. Pharmaceutical Research. 17(2):2000;168-174.
6. Patton J., Bukar J., Nagarajan S. Inhaled insulin. Advanced Drug Delivery Reviews. 35:1999;235-247.
7. Dunne M., Corrigan O.I., Ramtoola Z. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co- glycolide particles. Biomaterials. 21:2000;1659-1668.
8. Inhale Therapeutic Systems Inhale reports on phase III Exubera. The American Association of Clinical Endocrinologists' (AACE) 11th Annual Meeting and Clinical Congress, San Carlos, Ca, May:2002.
9. Zalipsky S. Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes. Bioconjugate Chemistry. 4(4):1993;296-299.
10. Hermanson G. Bioconjugate Techniques. 1996;Academic Press, New York.
11. Brady R., Ball R. Fractal growth of copper electrodeposits. Nature. 309:1984;225-229.
12. Feder F., Jossang T., Rosenqvist E. Scaling behavior and cluster fractal dimension determined by light scattering from aggregating proteins. Physical Review Letters. 53:1984;1403-1406.
13. Meakin P. Computer simulation of growth and aggregation processes of on growth and form: fractal and non-fractal patterns. Stanley E., Ostrowsky N. Physics. 1986;111-135 Nijhoff, Boston.
14. Mandelbrot B.B., Vespignani A., Kaufman H. Crosscut analysis of large radial DLA: departures from self-similarity and lacunarity effects. Europhysics Letters. 32:1995;199-204.
15. Kisak E.T., Kennedy M.T., Trommeshauser D., Zasadzinski J.A. Self-limiting aggregation by controlled ligand-receptor stoichiometry. Langmuir. 16(6):2000;2825-2831.
16. Zalipsky S., Qazen M., Walker J. II, Mullah N., Quinn Y., Huang S. New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipids, diacyl phosphatidylethanolamine. Bioconjugate Chemistry. 10(5):1999;703-707.
17. Bridges P., Taylor K. An investigation of some of the factors influencing the jet nebulization of liposomes. International Journal of Pharmaceutics. 204:2000;69-79.
18. Miyajima K. Role of saccharides for the freeze-thawing and freeze-drying of liposome. Advanced Drug Delivery Reviews. 24:1997;151-159.
19. Liu F., Shao Z., Kildsig D., Mitra A. Pulmonary delivery of free and liposomal insulin. Pharmaceutical Research. 10(2):1993;228-232.
20. Krill S.L., Harn J., Hahn K.R., Gupta S.L. Activity loss on room temperature storage of Survanta, a bovine lung extract based surfactant. International Journal of Pharmaceutics. 132:1996;89-94.
21. Wong J.Y., Kuhl T.L., Israelachvili J.N., Mullah N., Zalipsky S. Direct measurement of a tethered ligand-receptor interaction potential. Science. 275:1997;820-822.
22. S. Sood, Characterization of liposome manufacturing using extrusion, Master's Thesis, San Jose State University, 1999.
23. Lasic D.D., Ceh B., Stuart M.C.A., Guo L., Frederik P.M., Barenholz Y. Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery. Biochimica et Biophysica Acta. 1239:1995;145-156.
24. Tirosh O., Barenholz Y., Katzhendler J., Priev A. Hydration of polyethylene glycol-grafted liposomes. Biophysical Journal. 74:1998;1371-1379.
25. Wong J.P., Schnell G., Simpson M., Saravolac E. Effects of liposome-encapsulated ciprofloxacin on phagocytosis, nitric oxide production and intracellular killing of Staphylococcus aureus by murine macrophages. Presented at the 7th International Congress of Chemotherapy, Hong Kong:1996.
26. Dailey L.A., Schmehl T., Gessler T., Wittmar M., Grimminger F., Seeger W., Kissel T. Nebulization of biodegradable nanoparticle: impact of nebulizer technology and nanoparticle characteristics on aerosol features. Journal of Controlled Release. 86:2003;131-144.
27. Valente A., Langer R., Stone H.A., Edwards D.A. Recent advances in the development of an inhaled insulin product. Biodrugs. 17(1):2003;9-17.
28. Bot A., Tarara T., Smith D., Bot S., Woods C., Weers J. Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract. Pharmaceutical Research. 17(3):2000;275-283.
29. Finlay W.H., Stapletont K.W. Undersizing of droplets from a vented nebulizer caused by aerosol heating during transit through an anderson impactor. Journal of Aerosol Science. 30(1):1999;105-109.
30. Desai T.R., Hancock R.E.W., Finlay W.H. A facile method of delivery of liposomes by nebulization. Journal of Controlled Release. 84:2002;69-78.